非维生素K 拮抗剂口服抗凝药治疗房颤的新进展
杨洁， 王晓明 - 心脏杂志, 2019 - heartj.cn
… Warfarin, as a traditional oral anticoagulant, has been recognized for its efficacy and
safety. However, its narrow therapeutic window, frequent monitoring and other deficiencies of …
safety. However, its narrow therapeutic window, frequent monitoring and other deficiencies of …
[PDF][PDF] 基于美国FDA 不良事件报告数据库的达比加群酯相关出血事件信号检测与分析
田晓江， 王晓莉， 王柯静， 陈琳 - 药物不良反应杂志, 2020 - cadrj.com
… (13.89%) patients were <75 years … dabigatran etexilate was 110 mg once daily in 416 patients
(2.11%), 110 mg twice daily in 2 346 patients (11.89%), 150 mg once daily in 525 patients (…
(2.11%), 110 mg twice daily in 2 346 patients (11.89%), 150 mg once daily in 525 patients (…